Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • The Dose (New Items)
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

MAPS in the Media

Greenmarket Report: Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs

The bill – HD 2137, by state Rep. Nicholas Boldyga – was introduced in January, apparently in response to reporting by The Washington Post and The New York Times regarding moves by the nonprofit …
March 29, 2023

Psychedelic Spotlight: 5 Essential Steps To Become a Psychedelic Therapist: The Complete Guide

Becoming a psychedelic therapist requires vigorous training, psychedelic education, and extreme tenacity to grind through the uncertainty of the legality and creation of this career path. Originally appearing …
March 8, 2023

Tim Ferriss Show: Dr. Andrew Huberman — The Foundations of Physical and Mental Performance, Core Supplements, Sexual Health and Fertility, Sleep Optimization, Psychedelics, and More

Andrew Huberman, PhD (@hubermanlab), is a neuroscientist and tenured professor in the Department of Neurobiology at Stanford University’s School of Medicine. He has made numerous important contributions …
March 8, 2023

Disrupt Everything: Rick Doblin: a masterclass on psychedelic science, therapy and experience, MAPS, drug reform and proving safety and efficacy, the progress on MDMA therapy for legalization, LSD, thoughts on psilocybin and best practices – podcast #223

In this conversation, Rick and Isra cover much ground on psychedelics, from set & setting and preparation and integration to Rick’s best practices, personal LSD, MDMA and psilocybin journeys …
February 27, 2023

Australian Broadcasting Corporation: Virtual reality plus psychedelics are being trialled in therapy. Are they effective?

You’re having a VR program that’s supposed to somehow remind you of your own inner imagery, so it will be not as precise as your own imagination. -Rick Doblin Originally appearing here (Archived)
February 19, 2023

Benzinga: Women’s Footprint In Psychedelics Is Undeniable, Benzinga’s Psychedelics Advisory Council’s Six New Trailblazers

In its capacityas afinancial news and media outlet,Benzinga has added six new members to its Psychedelics Advisory Council. The new members includerenowned authorAmanda Siebert; Revitalist Lifestyle & …
February 10, 2023

The Denver Post: Aaron Rodgers, Tim Ferriss and more coming to psychedelics conference this summer

Green Bay Packers quarterback Aaron Rodgers and prominent podcaster Tim Ferriss are among thedozens of speakersmaking a trip to Denver this summer for a conference dedicated to all things psychedelics. …
February 7, 2023

Marijuana Moment: Australia Legalizes Psilocybin And MDMA Prescriptions As U.S. Patients Seek Similar Authorization

“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” Rick Doblin, executive director …
February 6, 2023

NY Daily News: Australia authorizes medical use of MDMA, magic mushrooms

“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” MAPS founder and director Dr. …
February 3, 2023

Common Dreams: Australia Legalizes Therapeutic Use of MDMA and Psilocybin

After decades of criminalization, Australia’s government said Friday that it will legalize the prescription of MDMA and psilocybin for the treatment of two medical conditions, a historic move hailed …
February 3, 2023

Psychedelic Alpha: The Balance at MAPS Between Public Benefit and Private Profit

Summary: “At this moment, when two successful Phase 3 studies of MDMA-assisted therapy for PTSD have brought us closer to potential FDA approval than ever before, MAPS and MAPS PBC must faithfully …
January 30, 2023

Technology Networks: The Future of Science – Humanity Takes a Front SeatTechnology Networks:

Summary: Technology Networks explores the rapid evolution seen in the world of science today, highlighting the potential benefits of psychedelic-assisted therapy. “The use of marijuana for medical …
January 27, 2023

Posts pagination

Newer Posts Page 1 … Page 4 … Page 261 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Designed with WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide